Physician profile
Jonathan M Holmes
NPI 1003895897
$1,477.95
in general payments reported to CMS, 2019-2025
10 companies · $688 in 2025
The $688 reported for 2025 was more than what 85% of Pediatric Ophthalmology and Strabismus Specialist providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $140 · 2023: $139 · 2024: $405 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $333.99 | 2025 | |
| Amgen INC. | $246.78 | 2024 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $158.42 | 2024 | Humphrey Hfa |
| Glaukos Corporation | $148.16 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $146.21 | 2025 | Acthar |
| Apellis Pharmaceuticals, INC. | $120.18 | 2025 | Syfovre |
| Abbvie INC. | $114.68 | 2023 | |
| Horizon Therapeutics Plc | $106.19 | 2021 | |
| Alcon Vision LLC | $87.20 | 2025 | Unity |
| Bausch & Lomb Americas INC. | $16.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.